Navigation Links
Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers
Date:3/10/2008

Tampa, Fla.- Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovarian cancers, according to researchers from The University of Texas M. D. Anderson Cancer Center. The findings were reported at the Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers.

The retrospective study is the first to analyze how women with low-grade tumors respond to chemotherapy in recurrent setting and confirms clinical impressions that the tumors are chemoresistant, said lead author David M. Gershenson, M.D., professor and chair of the Department of Gynecologic Oncology at M. D. Anderson. Previous studies have shown similar tumor resistance in newly diagnosed patients, and there is currently no standard of care for women facing the disease.

The results support a growing body of research that shows low-grade ovarian tumors behave differently than their high-grade counterparts, genetically and clinically. "In order to make meaningful advances in treatment, women with low-grade ovarian tumors must not be grouped together with those with more common ovarian tumors. They require unique consideration and more targeted treatment options for a better chance of survival," Gershenson said.

Gershenson and his colleagues identified all patients treated for recurrent low-grade serous carcinoma of the ovary seen at M. D. Anderson from 1990 through 2007 using databases from the Department of Gynecologic Oncology. Out of 52 patients with sufficient clinical information with which to assess response to one or more of 98 different chemotherapy regimens, the overall response rate was only 4 percent. Specifically, researchers found:

  • Among 24 patients who received carboplatin for platinum-sensitive disease, there were two partial responses and one complete response.
  • Of 11 patients who received a taxane/platinum c
    '/>"/>

Contact: Robyn Stein
robyn.stein@gabbe.com
212-220-4444
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Experimental drug boosts survival in recurrent ovarian cancer
2. Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
3. Antegrade bowel intussusception can cause recurrent, chronic postoperative intestinal obstruction
4. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
5. U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer
6. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
7. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
8. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
9. A new chemotherapeutic target for hepatocellular carcinoma
10. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
11. How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs and alcohol ... Strawbridge, gives a new approach on solutions in his new book ":Unraveling The ... and employees getting together for meaningful group meetings. "This would educate the employees ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... patient loyalty at a low cost. Personalized with practice contact information and logos, ... patients. Dental offices can also incorporate Calendars into seasonal mailings, thank you and ...
(Date:8/28/2015)... ... August 28, 2015 , ... Healthpointe clinics throughout ... deep sea diving. The act of recreational diving exposes the body to ... it is vital that all recreational and professional divers undergo regular comprehensive scuba ...
(Date:8/28/2015)... ... August 28, 2015 , ... Popular review site Top5MillionaireDatingSites.com recently ... sites . According to the listings, MillionaireMatch.com bags the top spot ... A spokesperson of Top5MillionaireDatingSites.com said, “This website has been designed to ...
(Date:8/28/2015)... Livermore, CA (PRWEB) , ... August 28, 2015 , ... ... annual Inc. 5000 list, an exclusive ranking of the nation’s fastest-growing private companies. The ... list’s history. With sales growth of 85% over the last three years, PREVENT ranks ...
Breaking Medicine News(10 mins):Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Healthpointe Now Offering Scuba Physicals 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2
... Tuesday, October 2, 2007, the,Detroit Economic Club (DEC) ... McKesson Corporation. The meeting will be held at ... Chairman and CEO of McKesson, the $100 billion ... market-based, "retail-like",healthcare -- a true "system" of healthcare ...
... Republican,presidential contenders have stood stubbornly behind President Bush on,issue ... standing behind his threat,to veto health care for low-income ... McCain, Mitt Romney and Fred Thompson veto,the children,s health ... The bill came up for discussion during an August ...
... Pass an Identical Bill, WASHINGTON, Sep. 25 ... H.R. 1943, The Stop AIDS,in Prison Act of 2007 ... in April would provide routine non-mandatory (opt out) HIV,counseling ... and allow,inmates to request an HIV test while ensuring ...
... fatty acids were less likely to develop diabetes, study says, ... risk for developing type 1 diabetes might be able to ... acids, a new study suggests. , Reporting in the Sept. ... Association , researchers from the University of Colorado found that ...
... CHASE, Md., Sept. 25 Garland Miller,President of the ... Congressional reception to benefit the Fund on Wednesday evening,September ... donations to the,Fund go directly to wounded soldiers or ... other costs." Miller further stated that, "the Fund ...
... AstraZeneca (NYSE:,AZN), a global leader in the pharmaceutical ... Companies" to work for by Working Mother magazine ... the company,s commitment,to work-life balance, retention and advancement ... designed to keep its employees,happy and healthy, and ...
Cached Medicine News:Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 2Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 3Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 4Health News:House of Representatives Passes Stop AIDS in Prison Act of 2007 2Health News:Omega-3s Guard Against Type 1 Diabetes 2Health News:Omega-3s Guard Against Type 1 Diabetes 3Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 2Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 3Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 4
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/28/2015)... y LONDRES, 28 de agosto de 2015 ... anunció hoy su participación en el  Congreso de ... soluciones cardiológicas más recientes y novedosas, entre ellas ... conectan a las personas y la tecnología con ... a diagnosticar, guiar los tratamientos y permitir atención ...
(Date:8/28/2015)... , August 28, 2015 The ... reach USD 49.12 billion by 2020, growing at a ... a new report by Grand View Research, Inc. Monitoring ... of 49.7% from 2014 to 2020.      ... population along with rising incidences of chronic diseases such ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
... ELGX ), developer of minimally invasive treatments ... a definitive agreement to acquire Nellix, Inc, a privately-held ... for the treatment of Abdominal Aortic Aneurysms (AAAs). ... will acquire Nellix for $15 million in stock at ...
... build on Abbott,s existing philanthropic partnerships to expand access ... and the Abbott Fund have provided more than $34 ... health needs in Haiti, including maternal and child health, ... Products Supported Early Relief Efforts Abbott ...
Cached Medicine Technology:Endologix to Acquire Nellix 2Endologix to Acquire Nellix 3Endologix to Acquire Nellix 4Endologix to Acquire Nellix 5Endologix to Acquire Nellix 6Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: